These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 37452154)

  • 1. Nocturnal systolic blood pressure dipping and progression of chronic kidney disease.
    Park CH; Jhee JH; Chun KH; Seo J; Lee CJ; Park SH; Hwang JT; Han SH; Kang SW; Park S; Yoo TH
    Hypertens Res; 2024 Jan; 47(1):215-224. PubMed ID: 37452154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reproducibility of daytime hypertension, night-time hypertension, and nocturnal blood pressure dipping patterns in young to middle age patients with stage 1 hypertension.
    Palatini P; Battista F; Mos L; Rattazzi M; Ermolao A; Vriz O; Mazzer A; Saladini F
    J Hypertens; 2025 Jan; 43(1):128-135. PubMed ID: 39288253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Decision Support for Hypertension Management in Chronic Kidney Disease: A Randomized Clinical Trial.
    Samal L; Kilgallon JL; Lipsitz S; Baer HJ; McCoy A; Gannon M; Noonan S; Dunk R; Chen SW; Chay WI; Fay R; Garabedian PM; Wu E; Wien M; Blecker S; Salmasian H; Bonventre JV; McMahon GM; Bates DW; Waikar SS; Linder JA; Wright A; Dykes P
    JAMA Intern Med; 2024 May; 184(5):484-492. PubMed ID: 38466302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intensive Home Blood Pressure Lowering in Patients With Advanced CKD.
    Ku E; Copeland TP; McCulloch CE; Seth D; Carlos CA; Cho K; Malkina A; Lo LJ; Hsu RK
    Am J Kidney Dis; 2024 Oct; ():. PubMed ID: 39427725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synbiotics, prebiotics and probiotics for people with chronic kidney disease.
    Cooper TE; Khalid R; Chan S; Craig JC; Hawley CM; Howell M; Johnson DW; Jaure A; Teixeira-Pinto A; Wong G
    Cochrane Database Syst Rev; 2023 Oct; 10(10):CD013631. PubMed ID: 37870148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utility of a Systolic Blood Pressure Polygenic Risk Score With Chlorthalidone Response.
    Armstrong ND; Srinivasasainagendra V; Patki A; Jones AC; Parcha V; Pampana A; Broeckel U; Lange LA; Arora P; Limdi NA; Tiwari HK; Irvin MR
    JAMA Cardiol; 2024 Dec; 9(12):1134-1141. PubMed ID: 39441603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adolescent Body Mass Index and Early Chronic Kidney Disease in Young Adulthood.
    Tsur AM; Akavian I; Landau R; Derazne E; Tzur D; Vivante A; Grossman E; Rotem RS; Fishman B; Pinhas-Hamiel O; Afek A; Coresh J; Chodick G; Twig G
    JAMA Pediatr; 2024 Feb; 178(2):142-150. PubMed ID: 38079159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Education programmes for people with chronic kidney disease and diabetes.
    Cashmore BA; Cooper TE; Evangelidis NM; Green SC; Lopez-Vargas P; Tunnicliffe DJ
    Cochrane Database Syst Rev; 2024 Aug; 8(8):CD007374. PubMed ID: 39171639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of Anemia in Dementia Risk Among Veterans With Incident CKD.
    Koyama AK; Nee R; Yu W; Choudhury D; Heng F; Cheung AK; Norris KC; Cho ME; Yan G
    Am J Kidney Dis; 2023 Dec; 82(6):706-714. PubMed ID: 37516301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Higher blood pressure targets for hypertension in older adults.
    Falk JM; Froentjes L; Kirkwood JE; Heran BS; Kolber MR; Allan GM; Korownyk CS; Garrison SR
    Cochrane Database Syst Rev; 2024 Dec; 12(12):CD011575. PubMed ID: 39688187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diabetes as a risk factor for tuberculosis disease.
    Franco JV; Bongaerts B; Metzendorf MI; Risso A; Guo Y; Peña Silva L; Boeckmann M; Schlesinger S; Damen JA; Richter B; Baddeley A; Bastard M; Carlqvist A; Garcia-Casal MN; Hemmingsen B; Mavhunga F; Manne-Goehler J; Viney K
    Cochrane Database Syst Rev; 2024 Aug; 8(8):CD016013. PubMed ID: 39177079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early referral to specialist nephrology services for preventing the progression to end-stage kidney disease.
    Smart NA; Dieberg G; Ladhani M; Titus T
    Cochrane Database Syst Rev; 2014 Jun; (6):CD007333. PubMed ID: 24938824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis.
    Tunnicliffe DJ; Palmer SC; Cashmore BA; Saglimbene VM; Krishnasamy R; Lambert K; Johnson DW; Craig JC; Strippoli GF
    Cochrane Database Syst Rev; 2023 Nov; 11(11):CD007784. PubMed ID: 38018702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Undernutrition as a risk factor for tuberculosis disease.
    Franco JV; Bongaerts B; Metzendorf MI; Risso A; Guo Y; Peña Silva L; Boeckmann M; Schlesinger S; Damen JA; Richter B; Baddeley A; Bastard M; Carlqvist A; Garcia-Casal MN; Hemmingsen B; Mavhunga F; Manne-Goehler J; Viney K
    Cochrane Database Syst Rev; 2024 Jun; 6(6):CD015890. PubMed ID: 38860538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Associations of uric acid with the risk of cardiovascular disease and all-cause mortality among individuals with chronic kidney disease: the Kailuan Study.
    Li N; Cui L; Shu R; Song H; Wang J; Chen S; Han Y; Yu P; Yuan W; Wang J; Gao H; Huang T; Gao X; Wu S; Geng T
    Eur J Prev Cardiol; 2024 Dec; 31(17):2058-2066. PubMed ID: 38946352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chlorthalidone vs Hydrochlorothiazide and Kidney Outcomes in Patients With Hypertension: A Secondary Analysis of a Randomized Clinical Trial.
    Ishani A; Hau C; Raju S; Wise JK; Glassman PA; Taylor AA; Ferguson RE; Cushman WC; Leatherman SM
    JAMA Netw Open; 2024 Dec; 7(12):e2449576. PubMed ID: 39656458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of fixed-dose combinations of telmisartan/hydrochlorothiazide 40/12.5 mg and 80/12.5 mg and a fixed-dose combination of losartan/hydrochlorothiazide 50/12.5 mg in mild to moderate essential hypertension: pooled analysis of two multicenter, prospective, randomized, open-label, blinded-end point (PROBE) trials.
    Lacourcière Y; Neutel JM; Schumacher H
    Clin Ther; 2005 Nov; 27(11):1795-805. PubMed ID: 16368450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sex and gender as predictors for allograft and patient-relevant outcomes after kidney transplantation.
    Jayanti S; Beruni NA; Chui JN; Deng D; Liang A; Chong AS; Craig JC; Foster B; Howell M; Kim S; Mannon RB; Sapir-Pichhadze R; Scholes-Robertson NJ; Strauss AT; Jaure A; West L; Cooper TE; Wong G
    Cochrane Database Syst Rev; 2024 Dec; 12(12):CD014966. PubMed ID: 39698949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone.
    Lee CC; Chen CW; Yen HK; Lin YP; Lai CY; Wang JL; Groot OQ; Janssen SJ; Schwab JH; Hsu FM; Lin WH
    Clin Orthop Relat Res; 2024 Dec; 482(12):2193-2208. PubMed ID: 39051924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiorespiratory Fitness in Adolescence and Risk of Type 2 Diabetes in Late Adulthood: A Nationwide Sibling-Controlled Cohort Study.
    Ballin M; Ahlqvist VH; Berglind D; Brunström M; Angel HA; Henriksson P; Neovius M; Ortega FB; Nordström A; Nordström P
    medRxiv; 2024 Nov; ():. PubMed ID: 39649593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.